Trane Technologies Plc SEC Filings

Trane Technologies (TT) insider transaction: The company’s VP & Chief Accounting Officer reported a same‑day option exercise and sale on 10/30/2025. The filing shows an option exercise of 600 Ordinary Shares at $78.97 per share, followed by a sale of 600 Ordinary Shares at $440 per share pursuant to a Rule 10b5-1 plan adopted on June 11, 2025.

Following these transactions, the reporting person directly held 7,148 Ordinary Shares. In addition, 702.555 Ordinary Shares were held indirectly by the plan trustee. Derivative holdings included 3,201 stock options outstanding. The exercised option relates to a grant that vested in three annual installments beginning on February 5, 2020 and carries an expiration date of February 4, 2029.

Trane Technologies (TT) reported solid Q3 2025 results. Net revenues were $5,742.5 million, up from $5,441.2 million. Operating income rose to $1,165.3 million from $1,024.6 million. Diluted EPS was $3.78 versus $3.39. Net earnings attributable to the company were $847.6 million, compared with $772.0 million a year ago.

By region, Q3 revenues were $4,663.3 million in the Americas, $749.6 million in EMEA, and $329.6 million in Asia Pacific. For the first nine months, operating cash flow was $2,035.6 million, with capital expenditures of $277.2 million. The company repurchased $1.25 billion of shares year‑to‑date and an additional approximately $120 million after quarter end, and declared dividends totaling $2.82 per share year‑to‑date. Ordinary shares outstanding were 221,739,004 as of October 24, 2025.

Long‑term debt was $3,921.2 million, and two $1.0 billion revolving credit facilities were fully unused. The company completed acquisitions, including BrainBox AI, with $73.9 million of acquired intangibles and total goodwill increases contributing to a $6,444.3 million goodwill balance.

Elizabeth A. Elwell, identified as VP & Chief Accounting Officer of Trane Technologies plc (TT), reported insider transactions dated 10/01/2025 on a Form 4. The filing shows direct beneficial ownership following the reported transactions of 7,148 ordinary shares and an indirect holding of 702.557 ordinary shares held by the plan trustee. The report discloses transactions executed under a Rule 10b5-1 plan adopted on June 11, 2025. A stock option with an exercise price of $70.22 and an exercisable/expiration reference to 02/05/2028 is listed; the option schedule notes vesting in pro rata annual installments beginning 02/06/2019. The Form 4 was signed by an attorney-in-fact on 10/02/2025.

Form 144 notice by an insider of Trane Technologies plc (TT) indicates the proposed sale of 401 shares of common stock through UBS Financial Services on the NYSE. The securities were acquired and are proposed to be sold on 10/01/2025 following an exercise of stock options with cash payment on the same date. The filing lists an aggregate market value of $170,425.00 for the shares and shows 222,515,359 shares outstanding for the issuer. The filer reports no securities sold in the past three months and affirms they are not aware of undisclosed material adverse information relating to the issuer.

Victoria Lazar, identified as Senior Vice President and an officer/director of Trane Technologies plc (TT), filed an initial Form 3 reporting that she does not beneficially own any securities of the issuer as of the event date 09/29/2025. The filing lists her mailing address at C/O Trane Technologies Company LLC, 800-E Beaty Street, Davidson, NC 28036. The Form 3 was signed on behalf of the reporting person by Eric R. Waller, Attorney-in-Fact on 09/30/2025. No non-derivative or derivative securities are reported and no indirect ownership is disclosed.

Trane Technologies (TT) insider activity: Director and Chair/CEO David S. Regnery executed transactions on 09/02/2025 under a Rule 10b5-1 trading plan. He acquired 22,497 ordinary shares by exercising stock options at a conversion/exercise price of $62.53 per share, and concurrently disposed of 22,497 ordinary shares at a reported price of $410 per share. After these transactions his beneficial ownership decreased from 146,209.941 to 123,712.941 ordinary shares. The option referenced vested in pro rata installments beginning February 7, 2018.

Trane Technologies plc (TT) reported a Form 144 notice for a proposed sale of 22,497 common shares, with an aggregate market value of $9,223,770.00. The shares represent approximately 0.01% of the 222,515,359 shares outstanding and the sale is planned on 09/02/2025 on the NYSE through UBS Financial Services, Inc.

The filer indicates the shares were acquired on 09/02/2025 by exercise of a stock option from the issuer and paid in cash. The filing reports no other sales in the past three months and includes the signers representation about lack of undisclosed material adverse information.

Christopher J. Kuehn, Executive Vice President & CFO of Trane Technologies plc (TT), reported a non‑derivative transaction on 08/20/2025. The filing shows a Code G(1) transaction disposing of 300 Ordinary Shares as a gift to a charitable donor advised fund at a price of $0. After the reported transaction, the reporting person beneficially owned 61,244.6397 shares directly. The Form 4 was filed by one reporting person and signed by an attorney‑in‑fact on 08/21/2025.